<PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">39375953</PMID><DateRevised><Year>2024</Year><Month>10</Month><Day>08</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1365-2184</ISSN><JournalIssue CitedMedium="Internet"><PubDate><Year>2024</Year><Month>Oct</Month><Day>07</Day></PubDate></JournalIssue><Title>Cell proliferation</Title><ISOAbbreviation>Cell Prolif</ISOAbbreviation></Journal><ArticleTitle>Maternal infection with SARS-CoV-2 during early pregnancy induces hypoxia at the maternal-fetal interface.</ArticleTitle><Pagination><StartPage>e13749</StartPage><MedlinePgn>e13749</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1111/cpr.13749</ELocationID><Abstract><AbstractText>The coronavirus disease 2019 (COVID-19) pandemic increases the risk of adverse fetal outcomes during pregnancy. Maternal infection during pregnancy, particularly with cytomegalovirus (CMV), hepatitis B and C virus, and human immunodeficiency virus can have detrimental effects on both mother and fetus, potentially leading to adverse outcomes such as spontaneous abortion or neonatal infection. However, the impact of severe acute respiratory syndrome coronavirus (SARS-CoV-2) infection on the maternal-fetal interface remains poorly understood. In this study, we initially utilised immunofluorescence and immunohistochemical to investigate placental samples from pregnant women who were infected with SARS-CoV-2 during the first trimester. Our data indicate that infection in the first trimester induces an upregulation of hypoxia inducible factor (HIF) levels at the maternal-fetal interface. Subsequently, single-cell RNA sequencing and metabolomics sequencing analyses reveal alterations in maternal-fetal interface. Remarkably, immune cells exhibited low expression levels of HIF possibly associated with immune activation. Furthermore, our findings demonstrate a gradual reduction in transcriptome and metabolic changes as gestation progressed beyond 12-16 weeks compared to samples obtained at 6-8 weeks gestation. Overall, our study suggests that early-stage SARS-CoV-2 infection during the first trimester leads to severe hypoxia and aberrant cell metabolism at the maternal-fetal interface which gradually resolves as pregnancy progresses. Nevertheless, these abnormal changes may have long-term implications for maternal-fetal interface development.</AbstractText><CopyrightInformation>© 2024 The Author(s). Cell Proliferation published by Beijing Institute for Stem Cell and Regenerative Medicine and John Wiley &amp; Sons Ltd.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Shi</LastName><ForeName>Xiaohui</ForeName><Initials>X</Initials><Identifier Source="ORCID">0009-0004-2025-9674</Identifier><AffiliationInfo><Affiliation>Center for Reproductive Medicine of The Second Affiliated Hospital, Center for Regeneration and Cell Therapy of Zhejiang University-University of Edinburgh Institute (ZJU-UoE Institute), Zhejiang University School of Medicine, Zhejiang University, Hangzhou, Zhejiang, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xi</LastName><ForeName>Chenxiang</ForeName><Initials>C</Initials><Identifier Source="ORCID">0000-0002-7038-7840</Identifier><AffiliationInfo><Affiliation>Shanghai Key Laboratory of Maternal Fetal Medicine, Clinical and Translational Research Center of Shanghai First Maternity and Infant Hospital, Shanghai Institute of Maternal-Fetal Medicine and Gynecologic Oncology, Frontier Science Center for Stem Cell Research, School of Life Sciences and Technology, Tongji University, Shanghai, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dong</LastName><ForeName>Baoxing</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Shanghai Key Laboratory of Maternal Fetal Medicine, Clinical and Translational Research Center of Shanghai First Maternity and Infant Hospital, Shanghai Institute of Maternal-Fetal Medicine and Gynecologic Oncology, Frontier Science Center for Stem Cell Research, School of Life Sciences and Technology, Tongji University, Shanghai, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yan</LastName><ForeName>Zihui</ForeName><Initials>Z</Initials><Identifier Source="ORCID">0000-0002-5491-6810</Identifier><AffiliationInfo><Affiliation>Shanghai Key Laboratory of Maternal Fetal Medicine, Clinical and Translational Research Center of Shanghai First Maternity and Infant Hospital, Shanghai Institute of Maternal-Fetal Medicine and Gynecologic Oncology, Frontier Science Center for Stem Cell Research, School of Life Sciences and Technology, Tongji University, Shanghai, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Wenqiang</ForeName><Initials>W</Initials><Identifier Source="ORCID">0000-0002-5974-9900</Identifier><AffiliationInfo><Affiliation>Shanghai Key Laboratory of Maternal Fetal Medicine, Clinical and Translational Research Center of Shanghai First Maternity and Infant Hospital, Shanghai Institute of Maternal-Fetal Medicine and Gynecologic Oncology, Frontier Science Center for Stem Cell Research, School of Life Sciences and Technology, Tongji University, Shanghai, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gao</LastName><ForeName>Shaorong</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0003-1041-3928</Identifier><AffiliationInfo><Affiliation>Shanghai Key Laboratory of Maternal Fetal Medicine, Clinical and Translational Research Center of Shanghai First Maternity and Infant Hospital, Shanghai Institute of Maternal-Fetal Medicine and Gynecologic Oncology, Frontier Science Center for Stem Cell Research, School of Life Sciences and Technology, Tongji University, Shanghai, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Di</ForeName><Initials>D</Initials><Identifier Source="ORCID">0000-0002-9451-9721</Identifier><AffiliationInfo><Affiliation>Center for Reproductive Medicine of The Second Affiliated Hospital, Center for Regeneration and Cell Therapy of Zhejiang University-University of Edinburgh Institute (ZJU-UoE Institute), Zhejiang University School of Medicine, Zhejiang University, Hangzhou, Zhejiang, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Dr. Li Dak Sum and Yip Yio Chin Center for Stem Cell and Regenerative Medicine, Zhejiang University, Hangzhou, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>State Key Laboratory of Biobased Transportation Fuel Technology, Zhejiang University, Haining, Zhejiang, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>32270835</GrantID><Agency>National Natural Science Foundation of China awarded to DC</Agency><Country /></Grant><Grant><GrantID>Z22C129553</GrantID><Agency>Zhejiang Natural Science Foundation awarded to DC</Agency><Country /></Grant><Grant><Agency>Dr. Li Dak Sum &amp; Yip Yio Chin Development Fund for Regenerative Medicine, Zhejiang University, awarded to DC.</Agency><Country /></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>10</Month><Day>07</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Cell Prolif</MedlineTA><NlmUniqueID>9105195</NlmUniqueID><ISSNLinking>0960-7722</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>8</Month><Day>31</Day></PubMedPubDate><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>6</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>9</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>8</Day><Hour>10</Hour><Minute>18</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>8</Day><Hour>10</Hour><Minute>18</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>8</Day><Hour>1</Hour><Minute>53</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39375953</ArticleId><ArticleId IdType="doi">10.1111/cpr.13749</ArticleId></ArticleIdList><ReferenceList><Title>REFERENCES</Title><Reference><Citation>Yang H, Rao Z. Structural biology of SARS‐CoV‐2 and implications for therapeutic development. Nat Rev Microbiol. 2021;19:685‐700. doi:10.1038/s41579‐021‐00630‐8</Citation></Reference><Reference><Citation>Rosenbloom JI, Raghuraman N, Carter EB, Kelly JC. Coronavirus disease 2019 infection and hypertensive disorders of pregnancy. Am J Obstet Gynecol. 2021;224:623‐624. doi:10.1016/j.ajog.2021.03.001</Citation></Reference><Reference><Citation>Wei SQ, Bilodeau‐Bertrand M, Liu S, Auger N. The impact of COVID‐19 on pregnancy outcomes: a systematic review and meta‐analysis. CMAJ. 2021;193:E540‐E548. doi:10.1503/cmaj.202604</Citation></Reference><Reference><Citation>Boettcher LB, Metz TD. Maternal and neonatal outcomes following SARS‐CoV‐2 infection. Semin Fetal Neonatal Med. 2023;28:101428. doi:10.1016/j.siny.2023.101428</Citation></Reference><Reference><Citation>Vento‐Tormo R, Efremova M, Botting RA, et al. Single‐cell reconstruction of the early maternal–fetal interface in humans. Nature. 2018;563:347‐353. doi:10.1038/s41586‐018‐0698‐6</Citation></Reference><Reference><Citation>Greenbaum S, Averbukh I, Soon E, et al. A spatially resolved timeline of the human maternal–fetal interface. Nature. 2023;619:595‐605. doi:10.1038/s41586‐023‐06298‐9</Citation></Reference><Reference><Citation>Mor G, Aldo P, Alvero AB. The unique immunological and microbial aspects of pregnancy. Nat Rev Immunol. 2017;17:469‐482. doi:10.1038/nri.2017.64</Citation></Reference><Reference><Citation>James JL, Carter AM, Chamley LW. Human placentation from nidation to 5 weeks of gestation. Part I: what do we know about formative placental development following implantation? Placenta. 2012;33:327‐334. doi:10.1016/j.placenta.2012.01.020</Citation></Reference><Reference><Citation>Patel J, Landers K, Mortimer RH, Richard K. Regulation of hypoxia inducible factors (HIF) in hypoxia and normoxia during placental development. Placenta. 2010;31:951‐957. doi:10.1016/j.placenta.2010.08.008</Citation></Reference><Reference><Citation>Genbacev O, Zhou Y, Ludlow JW, Fisher SJ. Regulation of human placental development by oxygen tension. Science. 1997;277:1669‐1672. doi:10.1126/science.277.5332.1669</Citation></Reference><Reference><Citation>Caniggia I, Mostachfi H, Winter J, et al. Hypoxia‐inducible factor‐1 mediates the biological effects of oxygen on human trophoblast differentiation through TGFβ3. J Clin Invest. 2000;105:577‐587. doi:10.1172/JCI8316</Citation></Reference><Reference><Citation>Caniggia I, Winter JL. Adriana and Luisa Castellucci award lecture 2001 hypoxia inducible factor‐1: oxygen regulation of trophoblast differentiation in normal and pre‐eclamptic pregnancies—a review. Placenta. 2002;23:S47‐S57. doi:10.1053/plac.2002.0815</Citation></Reference><Reference><Citation>Pringle KG, Kind KL, Sferruzzi‐Perri AN, Thompson JG, Roberts CT. Beyond oxygen: complex regulation and activity of hypoxia inducible factors in pregnancy. Hum Reprod Update. 2010;16:415‐431. doi:10.1093/humupd/dmp046</Citation></Reference><Reference><Citation>Burton GJ, Woods AW, Jauniaux E, Kingdom JCP. Rheological and physiological consequences of conversion of the maternal spiral arteries for uteroplacental blood flow during human pregnancy. Placenta. 2009;30:473‐482. doi:10.1016/j.placenta.2009.02.009</Citation></Reference><Reference><Citation>Khong TY, Robertson WB. Placenta creta and placenta praevia creta. Placenta. 1987;8:399‐409. doi:10.1016/0143‐4004(87)90067‐1</Citation></Reference><Reference><Citation>Robertson WB, Khong TY, Brosens I, De Wolf F, Sheppard BL, Bonnar J. The placental bed biopsy: review from three European centers. Am J Obstet Gynecol. 1986;155:401‐412. doi:10.1016/0002‐9378(86)90843‐4</Citation></Reference><Reference><Citation>Dommisse J, Tiltman AJ. Placental bed biopsies in placental abruption. BJOG. 1992;99:651‐654. doi:10.1111/j.1471‐0528.1992.tb13848.x</Citation></Reference><Reference><Citation>Smith GCS, Crossley JA, Aitken DA, et al. First‐trimester placentation and the risk of antepartum stillbirth. JAMA. 2004;292:2249‐2254.</Citation></Reference><Reference><Citation>Luo Z, Tian M, Yang G, et al. Hypoxia signaling in human health and diseases: implications and prospects for therapeutics. Sig Transduct Target Ther. 2022;7:218. doi:10.1038/s41392‐022‐01080‐1</Citation></Reference><Reference><Citation>Bruick RK. Oxygen sensing in the hypoxic response pathway: regulation of the hypoxia‐inducible transcription factor. Genes Dev. 2003;17:2614‐2623. doi:10.1101/gad.1145503</Citation></Reference><Reference><Citation>Lee P, Chandel NS, Simon MC. Cellular adaptation to hypoxia through hypoxia inducible factors and beyond. Nat Rev Mol Cell Biol. 2020;21:268‐283. doi:10.1038/s41580‐020‐0227‐y</Citation></Reference><Reference><Citation>Xi C, Yan Z, Bai D, et al. Immune rebalancing at the maternal‐fetal interface of maternal SARS‐CoV‐2 infection during early pregnancy. Protein Cell. 2024;15:460‐473. doi:10.1093/procel/pwae006</Citation></Reference><Reference><Citation>Wei J, Liu X, Xiao W, et al. (2023). Phospholipid remodeling and its derivatives are associated with COVID‐19 severity. J Allergy Clin Immunol. 2023;151(5):1259–1268. doi:10.1016/j.jaci.2022.11.032</Citation></Reference><Reference><Citation>Zhou Y, Zhou B, Pache L, et al. Metascape provides a biologist‐oriented resource for the analysis of systems‐level datasets. Nat Commun. 2019;10:1523. doi:10.1038/s41467-019-09234-6</Citation></Reference><Reference><Citation>Liberzon A, Birger C, Thorvaldsdóttir H, Ghandi M, Mesirov JP, Tamayo P. The Molecular Signatures Database Hallmark Gene Set Collection. Cell Sys. 2015;1:417–425. doi:10.1016/j.cels.2015.12.004.</Citation></Reference><Reference><Citation>Jin S, Guerrero‐Juarez CF, Zhang L, et al. Inference and analysis of cell‐cell communication using Cell Chat. Nat Commun. 2021;12:1088. doi:10.1038/s41467‐021‐21246‐9</Citation></Reference><Reference><Citation>Ritchie HE, Oakes DJ, Kennedy D, Polson JW. Early gestational hypoxia and adverse developmental outcomes. Birth Defects Res. 2017;109:1358‐1376. doi:10.1002/bdr2.1136</Citation></Reference><Reference><Citation>Serebrovska ZO, Chong EY, Serebrovska TV, Tumanovska LV, Xi L. Hypoxia, HIF‐1α, and COVID‐19: from pathogenic factors to potential therapeutic targets. Acta Pharmacol Sin. 2020;41:1539‐1546. doi:10.1038/s41401‐020‐00554‐8</Citation></Reference><Reference><Citation>Ferreira LMR, Meissner TB, Tilburgs T, Strominger JL. HLA‐G: at the interface of maternal–fetal tolerance. Trends Immunol. 2017;38:272‐286. doi:10.1016/j.it.2017.01.009</Citation></Reference><Reference><Citation>Wakeland AK, Soncin F, Moretto‐Zita M, et al. Hypoxia directs human extravillous trophoblast differentiation in a hypoxia‐inducible factor‐dependent manner. Am J Pathol. 2017;187:767‐780. doi:10.1016/j.ajpath.2016.11.018</Citation></Reference><Reference><Citation>Hermiston ML, Xu Z, Weiss A. CD45: a critical regulator of signaling thresholds in immune cells. Annu Rev Immunol. 2003;21:107‐137. doi:10.1146/annurev.immunol.21.120601.140946</Citation></Reference><Reference><Citation>Midha AD, Zhou Y, Queliconi BB, et al. Organ‐specific fuel rewiring in acute and chronic hypoxia redistributes glucose and fatty acid metabolism. Cell Metab. 2023;35:504‐516.e5. doi:10.1016/j.cmet.2023.02.007</Citation></Reference><Reference><Citation>Jia H, Liu C, Li D, et al. Metabolomic analyses reveal new stage‐specific features of COVID‐19. Eur Respir J. 2022;59:2100284. doi:10.1183/13993003.00284‐2021</Citation></Reference><Reference><Citation>Semenza GL. HIF‐1: upstream and downstream of cancer metabolism. Curr Opin Genet Dev. 2010;20:51‐56. doi:10.1016/j.gde.2009.10.009</Citation></Reference><Reference><Citation>Semenza GL. Hypoxia‐inducible factors in physiology and medicine. Cell. 2012;148:399‐408. doi:10.1016/j.cell.2012.01.021</Citation></Reference><Reference><Citation>Yamashita T, Honda M, Takatori H, et al. Activation of lipogenic pathway correlates with cell proliferation and poor prognosis in hepatocellular carcinoma. J Hepatol. 2009;50:100‐110. doi:10.1016/j.jhep.2008.07.036</Citation></Reference><Reference><Citation>Zhang L, Fan Y, Yang Z, Yang M, Wong C‐Y. NIR‐II‐driven and glutathione depletion‐enhanced hypoxia‐irrelevant free radical nanogenerator for combined cancer therapy. J Nanobiotechnol. 2021;19:265. doi:10.1186/s12951‐021‐01003‐2</Citation></Reference><Reference><Citation>Gupta GS. The lactate and the lactate dehydrogenase in inflammatory diseases and major risk factors in COVID‐19 patients. Inflammation. 2022;45:2091‐2123. doi:10.1007/s10753‐022‐01680‐7</Citation></Reference><Reference><Citation>Di Guardo F, Di Grazia FM, Di Gregorio LM, et al. Poor maternal‐neonatal outcomes in pregnant patients with confirmed SARS‐Cov‐2 infection: analysis of 145 cases. Arch Gynecol Obstet. 2021;303:1483‐1488. doi:10.1007/s00404‐020‐05909‐4</Citation></Reference><Reference><Citation>Nie X, Qian L, Sun R, et al. Multi‐organ proteomic landscape of COVID‐19 autopsies. Cell. 2021;184:775‐791.e14. doi:10.1016/j.cell.2021.01.004</Citation></Reference><Reference><Citation>Yuen K‐S, Ye Z‐W, Fung S‐Y, Chan C‐P, Jin D‐Y. SARS‐CoV‐2 and COVID‐19: the most important research questions. Cell Biosci. 2020;10:40. doi:10.1186/s13578‐020‐00404‐4</Citation></Reference><Reference><Citation>Rutkai I, Mayer MG, Hellmers LM, et al. Neuropathology and virus in brain of SARS‐CoV‐2 infected non‐human primates. Nat Commun. 2022;13:1745. doi:10.1038/s41467‐022‐29440‐z</Citation></Reference><Reference><Citation>Jauniaux E, Watson AL, Hempstock J, Bao Y‐P, Skepper JN, Burton GJ. Onset of maternal arterial blood flow and placental oxidative stress. Am J Pathol. 2000;157:2111‐2122. doi:10.1016/S0002‐9440(10)64849‐3</Citation></Reference><Reference><Citation>Valencia DN. Brief review on COVID‐19: the 2020 pandemic caused by SARS‐CoV‐2. Cureus. 2020;12:e7386. doi:10.7759/cureus.7386</Citation></Reference><Reference><Citation>Yockey LJ, Lucas C, Iwasaki A. Contributions of maternal and fetal antiviral immunity in congenital disease. Science. 2020;368:608‐612. doi:10.1126/science.aaz1960</Citation></Reference></ReferenceList></PubmedData></PubmedArticle>